Back to User profile » Dr Chih-Cheng Lai

Papers published by Dr Chih-Cheng Lai:


Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia

Chen CH, Tu CY, Chen WC, Kuo LK, Wang YT, Fu PK, Ku SC, Fang WF, Chen CM, Lai CC

Infection and Drug Resistance 2021, 14:2251-2258

Published Date: 16 June 2021

Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011–2012

Wang CY, Hu YL, Wang YH, Chen CH, Lai CC, Huang KL

Infection and Drug Resistance 2019, 12:2251-2257

Published Date: 22 July 2019

Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan

Lai CC, Chen CC, Lu YC, Chen HJ, Su BA, Weng TC, Chiu YH, Toh HS, Zhang CC, Chiang SR, Chuang YC, Tang HJ

Infection and Drug Resistance 2018, 11:2555-2560

Published Date: 7 December 2018

The association between COPD and outcomes of patients with advanced chronic kidney disease

Lai CC, Wu CH, Wang YH, Wang CY, Wu VC, Chen L

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2899-2905

Published Date: 17 September 2018

Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms

Lai CC, Chen CC, Lu YC, Lin TP, Chuang YC, Tang HJ

Infection and Drug Resistance 2018, 11:1441-1445

Published Date: 11 September 2018

The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA

Lai CC, Chen CC, Lu YC, Chuang YC, Tang HJ

Infection and Drug Resistance 2018, 11:681-687

Published Date: 3 May 2018

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD

Huang YL, Lai CC, Wang YH, Wang CY, Wang JY, Wang HC, Yu CJ, Chen LW

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2987-2996

Published Date: 11 October 2017